GENET-news
To stay informed you can subscribe to the GENET-news list.
2007-06-25 | permalink
New GE pharma plants: mosses and Mushrooms
German biotech company, Greenovation has received a broad ranging US patent for its unique moss-based biopharmaceutical production technology. The company’s first US patent covers the use of plant-based glycol-engineering and offers wide-ranging protection for the processing of plant-specific sugar residues as an alternative to conventional production techniques. By genetically engineering mosses to produce specific proteins as well as to over-express the glycotransferases that glycosylate the proteins, biopharmaceutical products can be produced in a cost effective and safe manner.
Overview
News
2007-06-25 | permalink
New GE pharma plants: mosses and Mushrooms
German biotech company, Greenovation has received a broad ranging US patent for its unique moss-based biopharmaceutical production technology. The company’s first US patent covers the use of plant-based glycol-engineering and offers wide-ranging protection for the processing of plant-specific sugar residues as an alternative to conventional production techniques. By genetically engineering mosses to produce specific proteins as well as to over-express the glycotransferases that glycosylate the proteins, biopharmaceutical products can be produced in a cost effective and safe manner.
GENET-news & GENET-forum
GENET-news is providing a daily news service on a range of topics regarding genetic engineering. We are screening the worldwide English news, press releases and other publications to provide you with a strategic selection of information. GENET-news enables you to stay informed about all aspects of the global controversy around GE technologies and GE organisms. You can subscribe by 
email.
The GENET-forum list provides you with additional background information and more voluminous reports. It is only open for GENET members. Please contact the coordinator for membership and subscription.